Received Jun 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MEN | MENINGOCOCCAL (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | U8375AB | OT / RA |
| MMR | MEASLES + MUMPS + RUBELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
accidentally given MENQUADFI to a 12-month-old patient instead of an MMR vaccine with no reported adverse event; Initial information received on 25-Jun-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 12 month old male patient who accidentally received Meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] to a 12-month-old patient instead of an Measles vaccine, Mumps vaccine, Rubella vaccine (MMR) with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 15-Jun-2025, the patient received a 0.5ml dose of suspect Meningococcal A-C-Y-W135 (T CONJ) vaccine Solution for injection, frequency-once (lot U8375AB and expiry date- 30-Apr-2028) via intramuscular route in the right arm for Immunization instead of Measles vaccine, Mumps vaccine, Rubella vaccine with no reported adverse event (latency-same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.